Medical News

RSS

Endo announces commercial availability of NATESTO nasal gel for men with hypogonadism

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), announced today the commercial availability of NATESTO (testosterone nasal gel), the first and only nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism.

16 Mar 2015

AcelRx announces dosing of first patient in pivotal ARX-04 Phase 3 study for treatment of acute pain

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today reported dosing of the first patient in the pivotal Phase 3 study of ARX-04.

16 Mar 2015

Egalet announces net revenues of $1.9 million for 2014

Egalet Corporation today reported financial results for the year ended December 31, 2014.

16 Mar 2015

Novimmune tests NI-0501 as first-line treatment for hemophagocytic lymphohistiocytosis

Novimmune SA announces that patients diagnosed with hemophagocytic lymphohistiocytosis (HLH), and who are participating in the company's ongoing clinical trial of its NI-0501 monoclonal antibody, will now be able to be treated with the drug without having to first fail conventional treatments.

16 Mar 2015

Ruthigen, Pulmatrix sign definitive merger agreement

Ruthigen, Inc., a biopharmaceutical company, and Pulmatrix, Inc., a Lexington, Massachusetts based clinical stage biotechnology company, announced today that on March 13, 2015, they have entered into a definitive merger agreement.

16 Mar 2015

Meta-analysis finds that high dose zinc acetate lozenges may help reduce duration of cold symptoms

According to a meta-analysis published in BMC Family Practice, high dose zinc acetate lozenges shortened the duration of common-cold associated nasal discharge by 34%, nasal congestion by 37%, scratchy throat by 33%, and cough by 46%.

16 Mar 2015

Cannabis use increases manic, depressive symptoms

The first study to examine the use of cannabis in the context of daily life among people with Bipolar Disorder has shown how the drug is linked to increases in both manic and depressive symptoms.

16 Mar 2015

Virginia Senator Creigh Deeds receives 2015 State Legislator of the Year Award

Virginia State Senator Creigh Deeds received the 2015 State Legislator of the Year Award from the American Psychological Association Practice Organization in recognition of his determination to improve mental health services and reduce stigma associated with mental illness. Sen. Deeds was presented with the award at a ceremony in Washington, D.C. on March 15.

16 Mar 2015

Scientists use x-ray vision to probe early stages of DNA 'photocopying'

Scientists at Johns Hopkins have created a 3-D model of a complex protein machine, ORC, which helps prepare DNA to be duplicated.

16 Mar 2015

Experts call for a tobacco-free world by 2040

Leading public health researchers have called for the sale of tobacco to be phased out by 2040, showing that with sufficient political support and stronger evidence-based action against the tobacco industry, a tobacco-free world – where less than 5% of adults use tobacco – could be possible in less than three decades.

16 Mar 2015

Healthy eating, exercise, and brain-training programme results in slower mental decline for older people

A comprehensive programme providing older people at risk of dementia with healthy eating guidance, exercise, brain training, and management of metabolic and vascular risk factors appears to slow down cognitive decline, according to the first ever randomised controlled trial of its kind, published in The Lancet.

16 Mar 2015

Boris backs Bump Mark with £20,000 prize

Brunel graduate Solveiga Pakstaite has added the Mayor of London’s Low Carbon Entrepreneur prize to the Dyson Award she won for her innovative final-year food label project – the Bump Mark.

16 Mar 2015

60,000 children in need of immediate assistance after Cyclone Pam in Vanuatu; at least 72,000 out of school

With Tropical Cyclone Pam ripping through Vanuatu from late Friday night (13th March) into the early hours of Saturday morning, UNICEF Pacific reminds that 45% of the population is children and they are particularly vulnerable in any emergency.

16 Mar 2015

Study: Countries most affected by Ebola outbreak may soon have 100,000 more measles cases

An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions.

16 Mar 2015

Common herpes drug Valacyclovir decreases HIV-1 levels

Case Western Reserve researchers are part of an international team that has discovered that a common herpes drug reduces HIV-1 levels — even when patients do not have herpes.

16 Mar 2015

Mayo Clinic researchers find that energy drinks may increase risk of cardiac events

Healthy young adults who don't consume caffeine regularly experienced greater rise in resting blood pressure after consumption of a commercially available energy drink — compared to a placebo drink — thus raising the concern that energy drinks may increase the risk of cardiac events, Mayo Clinic researchers found.

16 Mar 2015

Loyola's Bridget Boyd suggests ways to handle diaper rash

Diaper rash may not be a serious condition, but it can be extremely painful. It is common and causes concern for many parents trying to comfort their child.

16 Mar 2015

New antibody treatment blocks immune signaling protein crucial to psoriasis

Many patients suffering from psoriasis showed significant recovery after just a single dose of an experimental treatment with a human antibody that blocks an immune signaling protein crucial to the disease, researchers report.

16 Mar 2015

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

CTI BioPharma Corp. today announced that results of a Phase 2 study of pacritinib, in patients with myelofibrosis were published in the journal Blood. Pacritinib is a next-generation oral JAK2/FLT3 multikinase inhibitor currently in Phase 3 development in the PERSIST program.

16 Mar 2015

Potential solutions to help reduce high cost of cancer drugs in the U.S.

Increasingly high prices for cancer drugs are affecting patient care in the U.S. and the American health care system overall, say the authors of a special article published online in the journal Mayo Clinic Proceedings.

16 Mar 2015

Medical News

Endo announces commercial availability of NATESTO nasal gel for men with hypogonadism

AcelRx announces dosing of first patient in pivotal ARX-04 Phase 3 study for treatment of acute pain

Egalet announces net revenues of $1.9 million for 2014

Novimmune tests NI-0501 as first-line treatment for hemophagocytic lymphohistiocytosis

Ruthigen, Pulmatrix sign definitive merger agreement

Meta-analysis finds that high dose zinc acetate lozenges may help reduce duration of cold symptoms

Cannabis use increases manic, depressive symptoms

Virginia Senator Creigh Deeds receives 2015 State Legislator of the Year Award

Scientists use x-ray vision to probe early stages of DNA 'photocopying'

Experts call for a tobacco-free world by 2040

Healthy eating, exercise, and brain-training programme results in slower mental decline for older people

Boris backs Bump Mark with £20,000 prize

60,000 children in need of immediate assistance after Cyclone Pam in Vanuatu; at least 72,000 out of school

Study: Countries most affected by Ebola outbreak may soon have 100,000 more measles cases

Common herpes drug Valacyclovir decreases HIV-1 levels

Mayo Clinic researchers find that energy drinks may increase risk of cardiac events

Loyola's Bridget Boyd suggests ways to handle diaper rash

New antibody treatment blocks immune signaling protein crucial to psoriasis

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

Potential solutions to help reduce high cost of cancer drugs in the U.S.

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News